PTC Therapeutics Quarterly Balance Sheet
NASDAQ: PTCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
PTC Therapeutics financial position
As of Jun 30, 2026, PTC Therapeutics reported total assets of $3.25 billion, up 23.4% from a year earlier against total liabilities of $3.42 billion. Shareholders' equity was negative at -$165.4 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $1.05 billion in cash and equivalents against $591.0 million of debt, a net cash position of $458.9 million.
The current ratio (current assets divided by current liabilities) was 3.39, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
PTC Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.05B | 833.99M | 984.65M | 672.62M | 1.02B | 1.48B | 779.71M | 526.00M | 654.78M | 548.36M | 594.00M | 165.16M |
| Short-Term Investments | 1.18B | 1.06B | 960.72M | 1.02B | 971.76M | 546.95M | 359.99M | 487.36M | 438.51M | 336.46M | 282.74M | 129.65M |
| Receivables | 239.04M | 219.92M | 181.62M | 203.07M | 196.13M | 210.50M | 158.55M | 199.98M | 187.15M | 197.66M | 160.82M | 165.72M |
| Inventory | 91.35M | 75.57M | 79.65M | 52.69M | 34.06M | 21.68M | 23.19M | 35.67M | 31.83M | 30.06M | 30.58M | 35.75M |
| Total Current Assets | 2.62B | 2.25B | 2.27B | 2.01B | 2.27B | 2.32B | 1.37B | 1.28B | 1.36B | 1.17B | 1.22B | 540.36M |
| Property, Plant & Equipment | 51.49M | 52.74M | 55.37M | 56.97M | 57.19M | 59.46M | 60.97M | 63.17M | 65.99M | 92.78M | 87.09M | 85.03M |
| Goodwill | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Intangible Assets | 402.93M | 380.68M | 388.75M | 396.47M | 143.81M | 118.45M | 118.79M | 330.37M | 329.88M | 330.04M | 379.50M | 423.34M |
| Total Assets | 3.25B | 2.87B | 2.90B | 2.64B | 2.63B | 2.66B | 1.71B | 1.84B | 1.92B | 1.79B | 1.90B | 1.26B |
| Accounts Payable | 40.45M | 25.48M | 45.49M | 36.62M | 26.50M | 15.15M | 17.27M | 13.29M | 24.28M | 27.46M | 6.04M | 19.15M |
| Short-Term Debt | 55.45M | 286.94M | 286.63M | 286.32M | — | — | — | — | — | — | — | — |
| Total Current Liabilities | 771.07M | 923.60M | 968.43M | 866.25M | 627.81M | 595.39M | 580.98M | 610.71M | 609.80M | 574.55M | 603.10M | 492.12M |
| Long-Term Debt | 535.52M | — | — | — | 286.01M | 285.71M | 285.41M | 285.11M | 284.81M | 284.51M | 284.21M | 573.17M |
| Total Liabilities | 3.42B | 3.05B | 3.10B | 2.80B | 2.84B | 2.84B | 2.80B | 2.90B | 2.90B | 2.68B | 2.71B | 1.93B |
| Shareholders' Equity | -165.36M | -180.47M | -205.31M | -155.76M | -206.55M | -185.76M | -1.10B | -1.05B | -980.18M | -893.92M | -818.55M | -670.81M |
| Retained Earnings | -2.88B | -2.97B | -2.96B | -2.83B | -2.85B | -2.78B | -3.65B | -3.58B | -3.47B | -3.38B | -3.28B | -3.13B |
| Total Debt | 590.97M | 286.94M | 286.63M | 286.32M | 286.01M | 285.71M | 285.41M | 285.11M | 284.81M | 284.51M | 284.21M | 573.17M |
| Net Cash (Debt) | 1.64B | 1.61B | 1.66B | 1.40B | 1.70B | 1.74B | 854.28M | 728.25M | 808.49M | 600.30M | 592.53M | -278.36M |
| Shares Outstanding | 83.33M | 82.88M | 81.47M | 79.93M | 79.38M | 79.23M | 77.70M | 76.95M | 76.90M | 76.65M | 75.71M | 75.46M |
This table shows 12 quarterly periods of PTC Therapeutics's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PTCT's reporting calendar. What is a balance sheet?